Pharma Journalist -

Boehringer Ingelheim and Eli Lilly and Company announced results from the EMPERIAL-Reduced and EMPERIAL-Preserved trials related to functional endpoints with Jardiance (empagliflozin)…
Read More...

ViiV Healthcare, the global specialist HIV company majority-owned by GSK, with Pfizer Inc. and Shionogi Limited as shareholders, announced it has made regulatory submissions to both the…
Read More...

Pfizer Inc. announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending the approval of…
Read More...

Amarin Corporation plc announced that the U.S. Food and Drug Administration (FDA) has approved a new indication and label expansion for VASCEPA (icosapent ethyl) capsules. After more…
Read More...

Sarepta Therapeutics, Inc. announced that the U.S. Food and Drug Administration (FDA) has approved VYONDYS 53™ (golodirsen). VYONDYS 53 is an antisense oligonucleotide from Sarepta’s…
Read More...

Iktos, a company specialized in Artificial Intelligence for novel drug design and Almirall, S.A. (ALM), a leading skin-health focused global pharmaceutical company, announced a…
Read More...

Amneal Pharmaceuticals announced that it has received Abbreviated New Drug Application (ANDA) approval from the U.S. Food and Drug Administration (FDA) for EluRyng (etonogestrel/ethinyl…
Read More...

3M announced that it has entered into an agreement to sell substantially all of its drug delivery business to an affiliate of Altaris Capital Partners, LLC. Subject to closing and other…
Read More...

XBiotech Inc. announced that it has entered into a definitive agreement with Janssen Biotech, Inc., a Janssen Pharmaceutical Company of Johnson & Johnson, to sell XBiotech’s novel…
Read More...

Forendo Pharma, a clinical stage drug development company focusing on novel treatments in women's health, announces signing of a License and Collaboration Agreement with Novartis. The…
Read More...